SDF-1/CXCR4 expression in head and neck cancer and outcome after postoperative radiochemotherapy
Open Access
- 1 August 2017
- journal article
- research article
- Published by Elsevier in Clinical and Translational Radiation Oncology
- Vol. 5, 28-36
Abstract
No abstract availableKeywords
This publication has 63 references indexed in Scilit:
- Emerging targets in cancer management: role of the CXCL12/CXCR4 axisOncoTargets and Therapy, 2013
- CXCR4 Expression in Prostate Cancer Progenitor CellsPLOS ONE, 2012
- RNAi Targeting CXCR4 Inhibits Tumor Growth Through Inducing Cell Cycle Arrest and ApoptosisMolecular Therapy, 2012
- Intratumoural level of SDF-1 correlates with survival in head and neck squamous cell carcinomaOral Oncology, 2011
- CXCL12 (SDF1α)-CXCR4/CXCR7 Pathway Inhibition: An Emerging Sensitizer for Anticancer Therapies?Clinical Cancer Research, 2011
- CXCR4 Promotes Oral Squamous Cell Carcinoma Migration and Invasion through Inducing Expression of MMP-9 and MMP-13 via the ERK Signaling PathwayMolecular Cancer Research, 2011
- Recruitment of Myeloid but not Endothelial Precursor Cells Facilitates Tumor Regrowth after Local IrradiationCancer Research, 2010
- Inhibition of vasculogenesis, but not angiogenesis, prevents the recurrence of glioblastoma after irradiation in miceJournal of Clinical Investigation, 2010
- Nuclear Localization of CXCR4 Determines Prognosis for Colorectal Cancer PatientsCancer Microenvironment, 2008
- Expression of SDF-1α and nuclear CXCR4 predicts lymph node metastasis in colorectal cancerBritish Journal of Cancer, 2008